The research for this technology was conducted by Dr. Patricia Kruk at the University of South Florida in collaboration with H. Lee. Moffit Cancer Research Center and M. D. Anderson Cancer Center.


Key Findings of Scientific Study

    • Level of Bcl-2 is highly elevated in urine of women affected with ovarian cancer and this can be used as a specific biomarker for detection of ovarian cancer.
    • Bcl-2 is not elevated in other cancers and ovarian diseases such as endometriosis proving its high

The findings of the research was published in the Journal of Gynecologic Oncology.